Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
United States of America
COVID-19
Meningococcal disease
2021
Clear all
Type of publications
NITAG documentation
(34)
Systematic reviews (SYSVAC)
(3)
Topics
Regions
Americas
(37)
Countries
United States of America
(37)
Argentina
(1)
Australia
(11)
Belgium
(15)
Bolivia
(2)
Burkina Faso
(1)
Canada
(16)
Chile
(9)
China
(4)
Denmark
(1)
France
(16)
Germany
(8)
India
(1)
Ireland
(7)
Netherlands
(6)
Nigeria
(1)
Senegal
(2)
Spain
(1)
Sweden
(2)
Uganda
(12)
United Kingdom
(19)
Diseases
COVID-19
(36)
Meningococcal disease
(1)
Ebola
(1)
Human papillomavirus (HPV)
(4)
Publication date
2021
(37)
2023
(2)
2022
(17)
2020
(49)
2019
(2)
2018
(2)
2017
(1)
2016
(9)
2015
(4)
2014
(3)
2013
(2)
2011
(3)
2010
(1)
2009
(1)
2008
(1)
2007
(2)
2006
(3)
2005
(1)
1997
(1)
Target population
All age groups
(3)
Children
(2)
Healthcare workers
(1)
Parents/caregivers
(1)
Pregnant women
(3)
Available to download in languages
English (EN)
(34)
37 results found
2021
∙
Yasmin, F. Najeeb, H. Moeed, A. Naeem, U. Asghar, M. S. Chughtai, N. U. Yousaf, Z. Seboka, B. T. Ullah, I. Lin, C. Y. Pakpour, A. H.
COVID-19 Vaccine Hesitancy in the United States: A Systematic Review
2021
∙
Magesh, S. John, D. Li, W. T. Li, Y. Mattingly-App, A. Jain, S. Chang, E. Y. Ongkeko, W. M.
Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status: A Systematic-Review and Meta-analysis
2021
∙
Becerra-Culqui, T. A. Sy, L. S. Solano, Z. Tseng, H. F.
Real-world evidence of quadrivalent meningococcal conjugate vaccine safety in the United States: a systematic review
2021
∙
ACIP
Adverse events among children ages 5–11 years after COVID-19 vaccination: updates from v-safe and the Vaccine Adverse Event Reporting System (VAERS)
2021
∙
ACIP
COVID-19 Vaccine Safety Technical (VaST) Work Group
2021
∙
ACIP
Update on Omicron Variant
2021
∙
ACIP
Updates on Thrombosis with Thrombocytopenia Syndrome (TTS)
2021
∙
ACIP
Updates to the benefit/risk assessment for Janssen COVID-19 vaccines
2021
∙
ACIP
ACIP Evidence to Recommendations for Use of Janssen COVID-19 Vaccine under an Emergency Use Authorization
2021
∙
ACIP
ACIP Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years - May 12, 2021
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register